Epithelia are the tissue sheets that line every surface of your body, from skin to gut to airways, and roughly 80 to 90 percent of all human cancers arise from them. That statistic is not a coincidence. The very features that make epithelial cells so useful to the body, their tight organization, rapid turnover, and constant exposure to the outside world, also make them uniquely vulnerable to the mutations that drive cancer. Understanding how epithelia are built, what they do, and how they break down offers a surprisingly clear window into why cancer behaves the way it does.
How Epithelia Are Classified
Epithelial tissues are sorted by two criteria: how many cell layers they have, and the shape of the cells at the surface. The layering divides them into simple epithelia (a single cell layer) and stratified epithelia (multiple layers). Cell shape adds three main categories: squamous (flat, scale-like), cuboidal (roughly cube-shaped), and columnar (taller than they are wide). Combine the two and you get the standard types found in anatomy courses: simple squamous epithelium lines blood vessels and lung air sacs; simple columnar epithelium lines most of the gut; stratified squamous epithelium forms the outer skin and the lining of the mouth and esophagus.
A couple of special cases don’t fit neatly into the grid. Pseudostratified epithelium looks layered under a microscope because cell nuclei sit at different heights, but every cell actually touches the basement membrane, so it is technically a single layer. It lines most of the respiratory tract, where its cilia sweep mucus upward. Transitional epithelium, found in the bladder and ureters, can stretch and change shape as those organs fill and empty. These classifications matter clinically because the type of epithelium in a given organ determines the type of cancer that can develop there. A cancer arising from glandular columnar epithelium is an adenocarcinoma; one from squamous epithelium is a squamous cell carcinoma. Pathologists use this distinction every day when diagnosing tumors.
The Architecture That Holds It Together
Epithelial cells are not just stacked; they are engineered with a top, a bottom, and sides that behave differently from one another. The top (apical) surface faces the outside world or the interior of a hollow organ. The bottom (basal) surface sits on a specialized mat called the basement membrane. This apical-to-basal polarity governs everything from nutrient absorption to signal processing. Polarity proteins such as Crumbs help maintain this orientation, and they interact with growth-regulating pathways like the Hippo pathway, which controls organ size by restraining cell proliferation.
Between neighboring cells, four main types of junctions keep the tissue sealed and coordinated. Tight junctions near the apical surface form a selective gate that controls what passes between cells. Adherens junctions and desmosomes provide mechanical strength, with desmosomes anchoring to the intermediate filament skeleton of each cell to resist shearing forces. Gap junctions allow small molecules and electrical signals to pass directly from one cell to the next. These junctions don’t work in isolation; they cooperate physically and functionally to form an integrated network essential for tissue development and adult homeostasis.1PubMed Central. Desmosomes: Essential contributors to an integrated intercellular junction network
Beneath it all sits the basement membrane, a thin but complex sheet of extracellular molecules. It is composed of four primary components: collagens (especially type IV collagen), laminins, heparan sulfate proteoglycans, and nidogens, along with other molecules like fibronectin.2PubMed Central. Corneal epithelial basement membrane: Structure, function and regeneration Collagen IV and laminin self-assemble into two independent networks that are linked together by nidogen and perlecan to create a physically distinct sheet.3PubMed. Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology and Value as Fibrosis Biomarkers of Liver Disease Far from being a passive scaffold, this membrane stores and modulates growth factors that direct cell behavior during development, routine maintenance, and wound repair. In cancer, breaching this membrane is a defining event.
Barrier Function and Selective Permeability
One of the most critical jobs of any epithelium is acting as a gatekeeper. The tight junctions between cells don’t simply seal the space shut. Some tight-junction proteins form tiny extracellular channels that zigzag between neighboring cells, and these channels are selective: certain claudin proteins prefer cations, others prefer anions, and at least one (claudin-2) also lets water through.4Seminars in Cell & Developmental Biology. Tight junction, selective permeability, and related diseases Claudin-4, for example, forms channels that specifically reduce sodium permeability while leaving chloride permeability untouched.5JCI Insight. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability Hormones can tune these channels further; glucocorticoids in the lung increase expression of claudin-8, which tightens the barrier and shifts its selectivity toward chloride ions.6PubMed. Glucocorticoids Regulate Tight Junction Permeability of Lung Epithelia by Modulating Claudin 8
This selectivity is not academic trivia. It determines how your kidneys reclaim salt, how your intestines absorb nutrients, and how your lungs keep fluid from flooding the air sacs. When the system breaks down, the consequences are immediate and clinically serious.
Absorption, Secretion, and Immune Defense
The apical surface of many epithelial cells is covered in microvilli, tiny finger-like projections that massively increase the surface area available for absorbing nutrients.7PubMed. Sphingolipids controlling ciliary and microvillar function Intestinal enterocytes are the classic example. These microvilli also serve a defensive purpose: they create an electrostatic barrier that repels bacteria. One notable exception is the M cell, a specialized epithelial cell that lacks microvilli altogether, because its job is the opposite: to capture microbial particles from the gut lumen and hand them off to immune cells underneath.8PubMed Central. Epithelial microvilli establish an electrostatic barrier to microbial adhesion
Epithelial cells also produce and release a variety of molecules that contribute directly to mucosal immunity. In the gut, these include defensins (small antimicrobial peptides), lectins, mucins that form a protective gel layer, and secretory immunoglobulin A, all of which bind microbes and help maintain the barrier.9PubMed Central. Defensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut The sugar chains (glycans) coating the surface of intestinal epithelial cells are especially important: they serve as docking sites and nutrient sources for gut bacteria and help determine which microbial species live where.10PubMed Central. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD In other words, your epithelium doesn’t just tolerate your microbiome; it actively shapes it.
Stem Cells and the Speed of Renewal
Epithelial tissues are among the fastest-renewing in the body. The lining of your small intestine replaces itself roughly every four to five days. This pace requires a reliable pool of stem cells, and the identification of the Lgr5 gene as a stem cell marker was a breakthrough in understanding how it works. Lgr5-expressing cells at the base of intestinal crypts are genuine stem cells: they self-renew and can produce every differentiated cell type the intestinal lining needs.11PubMed Central. Wnt signaling, lgr5, and stem cells in the intestine and skin The same marker identifies stem cells in hair follicles, where Lgr5-positive cells maintain all hair follicle cell lineages over long periods.
For a while, researchers thought these stem cells depended entirely on support from neighboring Paneth cells in the crypt niche. Experiments in mice lacking Paneth cells showed otherwise: Lgr5-positive stem cells continued to proliferate, maintain active Wnt signaling, and generate differentiated progeny for months, even without Paneth cells present.12PubMed Central. Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells The stem cell machinery, in other words, is more robust and self-sufficient than the original niche model suggested. This resilience is a double-edged sword: it keeps your gut lining intact after an infection, but it also means that a stem cell carrying a cancer-driving mutation can persist and expand.
Metaplasia and Chronic Inflammation
When an epithelium is subjected to chronic irritation or inflammation, it sometimes responds by switching its identity. This process, called metaplasia, is the replacement of one mature cell type with another within the same tissue.13PubMed Central. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence The classic example is Barrett’s esophagus, where chronic acid reflux causes the normal squamous epithelium of the lower esophagus to be replaced by columnar cells resembling those in the intestine. The replacement is driven by shifts in which transcription factors are active, sometimes alongside changes in how genes are tagged for silencing or expression. In adult life, these metaplastic conversions happen frequently in some organs and are almost always associated with chronic inflammation and persistent irritation.14Trends in Molecular Medicine. Epithelia: Classification, Function, and Cancer
Metaplasia is usually reversible if the irritant is removed. But if it persists, the altered epithelium can progress through dysplasia (increasingly abnormal-looking cells) to frank carcinoma. This metaplasia-dysplasia-cancer sequence is one of the best-documented paths to epithelial cancer and is the reason clinicians monitor Barrett’s esophagus patients with regular endoscopies.
Even without a full identity switch, chronic inflammation damages epithelial barriers directly. In inflammatory bowel disease, the tight-junction strand pattern changes from continuous lines to a broken, particle-type appearance. Claudin-2 levels rise, letting cations and water leak into the gut lumen, which causes the watery diarrhea typical of the disease. Meanwhile, barrier-forming claudins and occludin are often reduced, which opens the paracellular route to larger molecules, including luminal pathogens that can trigger further immune responses.15Cellular and Molecular Gastroenterology and Hepatology. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease – Section: Impact of Barrier and Channel Properties of Tight Junction Proteins in Inflammatory Bowel Disease The result is a vicious cycle: barrier failure feeds inflammation, and inflammation worsens the barrier, creating the conditions in which cancer-driving mutations are more likely to stick.
How Epithelial Cancers Begin and Spread
Because the vast majority of cancers are carcinomas (cancers of epithelial origin), understanding the steps from a normal epithelial cell to an invasive tumor is central to oncology. The process typically starts with a loss of the polarity that normally keeps epithelial cells organized. When polarity pathways are disrupted, cells lose their normal spatial cues and begin to grow in disorganized patterns. Emerging evidence shows that this disruption alters the way epithelial cells interact with surrounding tissue, promoting both aberrant growth and the capacity to invade.16PubMed Central. Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis
A critical step in invasion is the epithelial-to-mesenchymal transition (EMT), in which epithelial cells shed their characteristic traits, tight junctions, apical-basal polarity, strong cell-cell adhesion, and take on properties of mesenchymal cells: increased motility, resistance to programmed cell death, and the ability to degrade surrounding tissue. Recent work has identified at least two distinct EMT programs operating in tumor cell populations. One drives invasion and dissemination, with sequential recruitment of transcription factors like Snail, Zeb1, and Prrx1 guiding cells toward a fully mesenchymal, pro-invasive state.17Nature Cancer. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations The other EMT program, identified in the same study, is linked more closely to inflammation within the tumor. This separation helps explain a long-standing puzzle: why some tumors are highly invasive while others seem stuck in a chronic inflammatory state without spreading aggressively.
For a tumor cell to cross from its tissue of origin into surrounding structures, it has to get through the basement membrane. Enzymes called matrix metalloproteinases handle this demolition. MT1-MMP, a membrane-anchored metalloproteinase that localizes to the leading edge of invasive cancer cells, degrades components of tissue barriers directly and also activates another enzyme, MMP-2, which can break down the type IV collagen that forms the backbone of basement membranes.18PubMed. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion Once the basement membrane is breached, cancer cells gain access to blood and lymph vessels, opening the door to metastasis.
Interestingly, the story does not end with EMT. When cancer cells reach a distant organ and begin to form a new tumor there, they often appear to reverse the process, undergoing a mesenchymal-to-epithelial transition (MET) to re-establish cell-cell adhesion and organize into a solid mass.19PubMed. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer This would explain a well-known observation: metastatic tumors frequently resemble the primary tumor histologically, looking far more “epithelial” than you would expect if the cells had stayed in a mesenchymal state during the entire journey.20Molecular Cancer Research. Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation Whether this switch is triggered by signals from the new tissue environment or programmed within the cancer cell itself remains an open question.
The Tumor Microenvironment and Its Accomplices
Cancer cells do not act alone. The tissue surrounding a tumor, called the tumor microenvironment, is populated by fibroblasts, immune cells, blood vessels, and extracellular matrix, all of which can be co-opted to support tumor growth. Cancer-associated fibroblasts (CAFs) are among the most influential accomplices. In colorectal cancer, CAFs shift their metabolism toward producing lactate and pyruvate, which neighboring cancer cells then use as fuel. CAFs also secrete signaling molecules like TGF-β, IL-6, and VEGF, which stimulate EMT, promote new blood vessel formation, and increase the tumor’s metastatic potential.21PubMed. Metabolic adaptation in colorectal cancer microenvironment: Focus on cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs)
Recent research has also shown that factors you might not expect can activate CAFs. In bile duct cancer (cholangiocarcinoma), excess bile acids activate a receptor on fibroblasts, prompting them to release a chemokine (CXCL10) that enhances EMT in cancer cells and simultaneously recruits immune-suppressive neutrophils, helping the tumor evade the immune system.22PubMed. Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma Findings like these illustrate how tightly woven together the metabolic, signaling, and immune dimensions of the tumor microenvironment really are.
Targeting Epithelial Cancer at the Molecular Level
One of the most successful applications of our understanding of epithelial biology to cancer treatment has been the development of drugs targeting the epidermal growth factor receptor (EGFR). EGFR is a transmembrane receptor found on epithelial cells that relays extracellular growth signals to the nucleus.23PubMed. An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy When EGFR is mutated or overexpressed, it can drive unchecked cell proliferation. Small-molecule kinase inhibitors and monoclonal antibodies that block EGFR have become standard therapies for several epithelial cancers, including non-small cell lung cancer, colorectal cancer, pancreatic cancer, breast cancer, and squamous cell carcinoma of the head and neck.24PubMed Central. Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
These drugs work, but resistance is nearly inevitable. Tumors evolve around the blockade through secondary mutations in EGFR itself, activation of parallel signaling pathways, or even by undergoing EMT to become less dependent on epithelial growth signals altogether. The ongoing arms race between new-generation EGFR inhibitors and the mutations tumors develop to evade them is one of the most active areas in clinical oncology. Understanding the epithelial biology behind the target, not just the target itself, helps researchers anticipate how resistance will emerge and where the next generation of drugs should aim.
Epithelia as the Oldest Multicellular Innovation
It is worth stepping back to appreciate how ancient this tissue type is. Epithelium is the first organized multicellular tissue found in evolution, forming a simple barrier between an organism’s interior and the outside environment.25PubMed Central. The evolutionary origin of epithelial cell-cell adhesion mechanisms Even sponges, which lack true tissues by most definitions, possess gene families for cell adhesion and polarity that are recognizable precursors to those used in modern animal epithelia.26PubMed. Origin of animal epithelia: insights from the sponge genome The core toolkit of adhesion molecules, polarity determinants, and basement membrane components was assembled very early in animal evolution and then elaborated upon as body plans grew more complex. Vertebrates, for example, added desmosomes to the junction repertoire, which enabled tissues to withstand far greater mechanical stress, a prerequisite for large, mobile bodies with skin, hearts, and guts.1PubMed Central. Desmosomes: Essential contributors to an integrated intercellular junction network
This deep evolutionary history helps explain why epithelial cancers are so common across the animal kingdom, not just in humans. The fundamental vulnerability, a rapidly dividing tissue exposed to environmental insults, has been present since before animals had bones. The gene networks controlling epithelial growth, polarity, and renewal are hundreds of millions of years old, and the mutations that derail them in cancer often hit the same conserved pathways regardless of species. In a sense, the price of the oldest and most versatile multicellular tissue is the oldest and most versatile category of cancer.